1,356
Views
13
CrossRef citations to date
0
Altmetric
Research Paper

The economic burden of childhood invasive pneumococcal diseases and pneumonia in Taiwan: Implications for a pneumococcal vaccination program

, , , &
Pages 1081-1087 | Received 21 Oct 2014, Accepted 21 Feb 2015, Published online: 27 May 2015

References

  • Kellner JD, Vanderkooi OG, MacDonald J, Church DL, Tyrrell GJ, Scheifele DW. Changing epidemiology of invasive pneumococcal disease in Canada, 1998-2007: update from the Calgary-area Streptococcus pneumoniae research (CASPER) study. Clin Infect Dis 2009; 49(2):205-12; PMID:19508165; http://dx.doi.org/10.1086/599827
  • O’Brien KL, Wolfson LJ, Watt JP, Henkle E, Deloria-Knoll M, McCall N, Lee E, Mulholland K, Levine OS, Cherian T. Burden of disease caused by Streptococcus pneumoniae in children younger than 5 years: global estimates. Lancet 2009; 374:893-902; PMID:19748398; http://dx.doi.org/10.1016/S0140-6736(09)61204-6
  • Casey JR, Pichichero ME. Changes in frequency and pathogens causing acute otitis media in 1995-2003. Pediatr Infect Dis J 2004; 23(9):824-8; PMID:15361720; http://dx.doi.org/10.1097/01.inf.0000136871.51792.19
  • Block SL, Hedrick J, Harrison CJ, Tyler R, Smith A, Findlay R, Keegan E. Community-wide vaccination with the heptavalent pneumococcal conjugate significantly alters the microbiology of acute otitis media. Pediatr Infect Dis J 2004; 23(9):829-33; PMID: 15361721
  • Murphy TF. Vaccine development for non-typeable Haemophilus influenza and Moraxella catarrhalis: progress and challenges. Expert Rev Vaccines 2005; 4(6):843-53[Review]; PMID:16372880; http://dx.doi.org/10.1586/14760584.4.6.843
  • O’Neill JM, St Geme JW 3rd, Cutter D, Adderson EE, Anyanwu J, Jacobs RF, Schutze GE. Invasive disease due to nontypeable Haemophilus influenzae among children in Arkansas. J Clin Microbiol 2003; 41(7):3064-9; PMID:12843045; http://dx.doi.org/10.1128/JCM.41.7.3064-3069.2003
  • Ladhani S, Slack MP, Heath PT, von Gottberg A, Chandra M, Ramsay ME; European Union Invasive Bacterial Infection Surveillance participants. Invasive Haemophilus influenzae Disease, Europe, 1996-2006. Emerg Infect Dis 2010. 16(3):455-63; PMID:20202421
  • Morrow A, De Wals P, Petit G, Guay M, Erickson LJ. The burden of pneumococcal disease in the Canadian population before routine use of the seven-valent pneumococcal conjugate vaccine. Can J Infect Dis Med Microbiol 2007; 18(2):121-7; PMID:18923713
  • World Health Organization. Pneumococcal conjugate vaccine for childhood immunization - WHO position paper. Wkly Epidemiol Rec 2007; 82(12):93-104; PMID:17380597
  • Pneumococcal vaccines WHO position paper -2012. Wkly Epidemiol Rec 2012; 87(14):129-44; PMID:24340399
  • Blank PR, Szucs TD. Cost-effectiveness of 13-valent pneumococcal conjugate vaccine in Switzerland. Vaccine 2012; 30(28):4267-75; PMID:22521287; http://dx.doi.org/10.1016/j.vaccine.2012.04.028
  • Strutton DR, Farkouh RA, Earnshaw SR, Hwang S, Theidel U, Kontodimas S, Klok R, Papanicolaou S. Cost-effectiveness of 13-valent pneumococcal conjugate vaccine: Germany, Greece, and The Netherlands. J Infect 2012; 64(1):54-67; PMID:22085813; http://dx.doi.org/10.1016/j.jinf.2011.10.015
  • Rubin JL, McGarry LJ, Strutton DR, Klugman KP, Pelton SI, Gilmore KE, Weinstein MC. Public health and economic impact of the 13-valent pneumococcal conjugate vaccine (PCV13) in the United States. Vaccine 2010; 28(48):7634-43. PMID:20883739; http://dx.doi.org/10.1016/j.vaccine.2010.09.049
  • Tyo KR, Rosen MM, Zeng W, Yap M, Pwee KH, Ang LW, Shepard DS. Cost- effectiveness of conjugate pneumococcal vaccination in Singapore: comparing estimates for 7-valent, 10-valent, and 13-valent vaccines. Vaccine 2011; 29(38):6686-94; PMID:21745516; http://dx.doi.org/10.1016/j.vaccine.2011.06.091
  • Chen YY. Streptococcus Pneumoniae infection in Taiwan, 2008-2010. Taiwan Epidemiol Bull 2011;27(22):297-304.
  • Trueman P, Drummond M, Hutton J. Developing guidance for budget impact analysis. Pharmacoeconomics 2001; 19:609-21; PMID:11456210; http://dx.doi.org/10.2165/00019053-200119060-00001
  • Chen YY, Yao SM, Chou CY, Chang YC, Shen PW, Huang CT, Su HP, Li SY. Surveillance of invasive Streptococcus pneumonia in Taiwan, 2002-2003. J Med Microbiol 2006; 55(Pt 8):1109-14; PMID:16849732; http://dx.doi.org/10.1099/jmm.0.46530-0
  • Lucero MG, Dulalia VE, Nillos LT, Williams G, Parreño RA, Nohynek H, Riley ID, Makela H. Pneumococcal conjugate vaccines for preventing vaccine-type invasive pneumococcal disease and X-ray defined pneumonia in children less than two years of age. Cochrane Database Syst Rev 2009; (4):CD004977; PMID:19821336; http://dx.doi.org/10.1002/14651858.CD004977.pub2
  • Jansen AG, Hak E, Veenhoven RH, Damoiseaux RA, Schilder AG, Sanders EA. Pneumococcal conjugate vaccines for preventing otitis media. Cochrane Database Syst Rev 2009; (2):CD001480; PMID:19370566; http://dx.doi.org/10.1002/14651858.CD001480.pub3
  • Nuorti JP, Whitney CG, Centers for Disease Control and Prevention (CDC). Prevention of pneumococcal disease among infants and children - use of 13-valent vaccine - recommendations of the Advisory Committee on Immunization Practices (ACIP). MMWR Recomm Rep 2010; 59(RR-11):1-18
  • Chen KT, Chen PY, Tang RB, Huang YF, Lee PI, Yang JY, Chen HY, Bresee J, Hummelman E, Glass R. Sentinel hospital surveillance for rotavirus diarrhea in Taiwan, 2001-2003. J Infect Dis 2005; 92:s44-8; PMID:16088804; http://dx.doi.org/10.1086/431495
  • Bureau of National Health Insurance, R.O.C. (Taiwan). The national health insurance annual statistical report, 2013. Accessed on 15 August 2014 by http://www.nhi.gov.tw/00english/e_index.htm
  • Sohn HS, Suh DC, Jang E, Kwon JW. Economic evaluation of childhood 7-valent pneumococcal conjugate vaccination in Korea. J Manag Care Pharm 2010; 16:32-45; PMID:20044845
  • Hoshi SL, Kondo M, Okubo I. Economic evaluation of vaccination programme of 13-valent pneumococcal conjugate vaccine to birth cohort in Japan. Vaccine 2013; 31:2762-71; PMID:23588088; http://dx.doi.org/10.1016/j.vaccine.2013.03.052
  • Kulpeng W, Leelahavarong P, Rattanavipapong W, Sornsrivichai V, Baggett HC, Meeyai A, Punpanich W, Teerawattananon Y. Cost-utility analysis of 10- and 13-valent pneumococcal conjugate vaccines: Protection at what price in the Thai context? Vaccine 2013; 31:2839-47; PMID:23588084; http://dx.doi.org/10.1016/j.vaccine.2013.03.047
  • Ho PL, Chiu SS, Chow FK, Mak GC, Lau YL. Pediatric hospitalization for pneumococcal diseases preventable by 7-valent pneumococcal conjugate vaccine in Hong Kong. Vaccine 2007; 25:6837-41; PMID:17714837; http://dx.doi.org/10.1016/j.vaccine.2007.07.039
  • Tanaka J, Ishiwada N, Wada A, Chang B, Hishiki H, Kurosaki T, Kohno Y. Incidence of childhood pneumonia and serotype and sequence-type distribution in Streptococcus pneumoniae isolates in Japan. Epidemiol Infect 2012; 140:1111-21; PMID:21875450; http://dx.doi.org/10.1017/S0950268811001592
  • Bureau of National Health Insurance, R.O.C. (Taiwan). The national health insurance annual statistical report, 2008. Accessed on 15 August 2014 by http://www.nhi.gov.tw/00english/eindex.htm
  • Guevara RE, Butler JC, Marston BJ, Plouffe JF, File TM Jr, Breiman RF. Accuracy of ICD-9-CM codes in detecting community-acquired pneumococcal pneumonia for incidence and vaccine efficacy studies. Am J Epidemiol 1999; 149:282-9; PMID:9927225; http://dx.doi.org/10.1093/oxfordjournals.aje.a009804
  • Chen SC, Hsiao-Ling Chang HL, Chen KT. The epidemiology of imported malaria in Taiwan between 2002-2013: the importance of sensitive surveillance and implications for pre-travel medical advice. Int J Environ Res Public Health 2014; 11(6):5651-64; PMID:24871257; http://dx.doi.org/10.3390/ijerph110605651
  • Centers for Disease Control, R.O.C. (Taiwan). Notifiable infectious disease statistical system. Available at http://nidss.cdc.gov.tw ( accessed on 14 May 2014).
  • Chang YK, Chen JY, Chang HL, Yu MC, Hsiao HF, Hou CC, Liu SY, Chen KT. Absence of endemic measles transmission in a highly vaccinated population from 1999 to 2008: implications of sustained measles elimination in Taiwan. Vaccine 2010; 28:5332-7; PMID:20665978; http://dx.doi.org/10.1016/j.vaccine.2010.05.047
  • Chen KT, Chang HL, Wang ST, Cheng YT, Yang JY. Epidemiologic features of hand-foot-mouth disease and herpangina caused by enterovirus 71 in Taiwan, 1998-2005. Pediatrics 2007; 120:e244-52; PMID:17671037; http://dx.doi.org/10.1542/peds.2006-3331
  • International Monetary Fund, Taiwan province of China: inflation, average consumer prices. World Economic Outlook Database. Available online at: www.imf.org. Accessed January 2014.
  • Rice DP, Hodgson TA, Kopstein AN. The economic costs of illness: a replication and update. Health Care Finance Rev 1985; 7:61-80; PMID:10311399
  • Murray CJ. Quantifying the burden of disease: the technical basis for disability-adjusted life years. Bull World Health Organ 1994; 72:429-45; PMID:8062401
  • Chiu SS, Ho PL, Khong PL, Ooi C, So LY, Wong WH, Chan EL. Population-based incidence of community-acquired pneumonia hospitalization in Hong Kong children younger than 5 years before universal conjugate pneumococcal immunization. J Microbiol Immunol Infect 2014 Jul 25. pii: S1684-1182(14)00104-2. http://dx.doi.org/10.1016/j.jmii.2014.05.007